The minimum follow-up duration of all patients is 6 months. PDF Abstract.
1995 Mar;13(3):588-95. doi: 10.1200/JCO.1995.13.3.588. h�b```f``�b`a`)`�g@ ~�rr��j$�q�ͫ��B��>�#}�d6��::$::8�HD`5�]��qR%�J��aNo8�We`�H3�H�10N����s�_�U�| �82
1648 0 obj <>stream
:z����㸂�v�P9&��B��-���YI�K^�Z������p�x���L��| ����,_����lމz֯�=��G#,ύ!3�*BA'D!7�2�I�YB1F�(�.^7��5�d��n� ���w�c�4�E�=#�� s�`za�R�-K�����`�gr蝹q�8�1��Ր���N*e)�������;3�yDZn����#O>��> Lko���?�.����XR�����̹���\�H��ɑ�3���ϧ����C0�bZdYrk1���#��7��>NI�(ǩg���t�@u�������oY�L�9�ټ]B��S^���UǞFe�yR����˽U6��&�K��\X. stream %�쏢 Chemotherapy Protocols for iPad By pdlsolutions ( $16.99 ) Chemotherapy Protocols Chemotherapy Protocols is a short and comprehensive summary of nearly 200 different chemotherapy protocols used daily in the treatment of 28 tumor entities all over the world. BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: analysis of efficacy, toxicity and prognostic factors Bone Marrow Transplant .
1629 0 obj <>/Filter/FlateDecode/ID[<8D641381EF675445A6FC3E07830A2FB3><41CD26D32F5C4B49A2EE67296CC2E516>]/Index[1612 37]/Info 1611 0 R/Length 85/Prev 129881/Root 1613 0 R/Size 1649/Type/XRef/W[1 2 1]>>stream 0
Alive
PURPOSE.
5'�~����2��h,{�+V�W��#M�N>@���>!��3��?�� ���]���WOg����""�)��v�3����a������-a2nȧ�Ir��u��N^�XN�rǀ�����E�dy E�X�\�M� 5 ��|$r�&��YcD�(K7� To evaluate the outcome of patients with relapsed or resistant non-Hodgkin's lymphoma (NHL) undergoing high-dose ... etoposide, cytarabine, and melphalan (BEAM) chemotherapy and ABMT at University College Hospitals between September 1981 and February 1993. endstream endobj 1613 0 obj <>/Metadata 53 0 R/Outlines 94 0 R/PageLayout/OneColumn/Pages 1608 0 R/StructTreeRoot 117 0 R/Type/Catalog>> endobj 1614 0 obj <>/Font<>>>/Rotate 0/StructParents 0/Tabs/S/Type/Page>> endobj 1615 0 obj <>stream Phase III Rituxan/BEAM vs. Bexxar/BEAM with Autologous Hematopoietic Stem Cell Transplantation (ASCT) for Persistent or Relapsed Chemotherapy Sensitive Diffuse Large BEAM Chemotherapy and Autologous Bone Marrow Transplantation for Patients With Relapsed or Refractory non-Hodgkin's Lymphoma J Clin Oncol .
Died Motoyama 1995 80 female lower hepatoid yes yes chemotherapy Bleomycin 2mo. BEAM chemotherapy is an acronym representing a small family of combination chemotherapy regimens that are used chiefly as salvage regimens in the context of Hodgkin's lymphoma that includes dexa-BEAM and mini-BEAM. Patients are irradiated by external beam radiation, using 3D conformal radiation technique. Treatment protocol prognosis Sawada 1993 80 male middle AFP-producingyes no paliative surgery+ chemotherapy Tegafur+ Lentinan 4mo.
They are also used as salvage or preparative … 1997 Sep;20(6):451-8. doi: 10.1038/sj.bmt.1700913. x��Z�v�8>{�O�;l��~-�+��a6���^,\d�L�a�ɒd���*�lKU��ݝ� 09g���O�ꫪO%�PI�t%�_j�ݬdu��a� ��i���r���[_��͇�!��w��Rt��`6 ooV�������[�R[�+��hۮ����矟��F��:�ϫ�w�� �+�FH�(�ʂ}{��J��)lW�V��a���?4k#Lp��/����$4�֬��:__7k-T�\W�6R�VJ��w��)�aX'�w�ԧ��Ѣ�I���F9�vr2����%���W�J7Q@���D�a��3�ȶ��w�:�t���Q��%Y�i�?���ք����u]}�+�>��.Wo�)��(y�(]� �P�᩶m�?��K-w:�L��������h�� ���9 �,E6{���wY���ꭟHuJ��O?6^tV9[?��/� x�r���(��hk�j �� ���!$���"3A�>�i���b�nqz�����yS�aE�d�w�z �w�&����d�k|_�k����T�y*�-"{�!#��]�nh�*���H�����1��`LB���bMB{!��DY�;���A~*⤧�I�s���{v�#^�5��@���5Z;l�+��=� 9�X'�ħ��'��gDK�r�$.
We performed a case control retrospective study of patients with NHL and HL who underwent high-dose chemotherapy (HDC) with BeEAM regimen between January 2015 and December 2015. %PDF-1.4 :�rԣ*�A�b?�+�=��md9�ä0C�H����.
It was developed by oncologists for oncologists.
5 0 obj
%PDF-1.5 %���� endstream endobj startxref BMT CLINICAL TRIALS NETWORK Rituxan/BEAM vs Bexxar/BEAM – Protocol 0401 Version 8.0 dated September 20, 2010 . 1612 0 obj <> endobj )�p��p�"*yϺ�Ѵ��}���"9�pоs A�?��r̷� j�`�[,8�]/
o ύb�ğ?Y���đ1�`�#�H�T���Cȱ�t��öo9���Zٹ��os���"�)Y$���(R���ZaJe��������=�;+�Rk�ЕS��z�W9U��j���HKl4s��+�1��%m�|x���"�E/!F�Tj�%��-� +��DA��`�=w��-ҭ�]�������-�f1 �$�p����۹��l��-ۗ%��k��~�G�r�R�¯7?����:%anBαy ��|��Rh`M>������幓LCd�ml���&��f2��x��˳oi��� �g�v ��4�'��W���y>�6P�vxM՝��K������ǹt�p�ě���e��x��v��"$Db8�ᓞ!��KT�7���ՔB�5˅�jo���"o'��|ǃa��qS�g��ᆙubq�D��J�-����L�ˣ �K2�`'!B��JD�{,�(�*�a������o�q�RT|�QP�O�Y�̃��^�D�+�Hڡp��ւ%����h��,��2��9�pn���l��1z�:�$��.C�P^-۰G�(K+,�O*~�|� E��1� XL����G��LDPHG�^�I��='������9��o8��S���L��7����PL���jrp�:�(S݂�Ȩ�̑�L�"���Ջ�A17w�hٓ���A���-�I�e��Jz=j�? PROTOCOL SYNOPSIS -BMT CTN PROTOCOL #0401 . We matched each BeEAM patient with two patients having the same age, sex and number of treatment lines who underwent BEAM and ASCT between January 2008 and December 2014. h��mo�F���~LT����� �K���J!W�">8�K���lG���ά�����VB���23;;3~H�F2�7�p�@��@�/7�D�C� p` �� F�AH�E�HHp"�Bm%��ƍ$�Z�O���Z�H
��[ Ȕ�tV�9VV�-b��ia� ���En������7��Iq"���EX�=�o��a����_Fk)�k��z�5I��q�`�Hɠ�I�YI!N��ӣ��y��`�:�x��P,����!�/+S#�1��wr�A����mJ�T*R�iE���s��"Y chemotherapy.
In detail, radiotherapy with concurrent intravenous chemotherapy is given according to the following scheme: radiotherapy with 41.4Gy given in 23 fractions of 1.8Gy: days 1-5, days 8-12, days 15-19, days 22-26 and days 29-31.
h�bbd``b`�$f � ��$��7��">��S �`�%��@��XHpE�Xa@�##�m���T'��^� � ��?
<> BC Cancer Protocol Summary for Treatment of Lymphoma with Dose-Adjusted Etoposide, DOXOrubicin, vinCRIStine, Cyclophosphamide, ... chemotherapy and for six months afterwards • cotrimoxazole 1 DS tab PO 3 times each week (Monday, Wednesday and Friday)
%%EOF
Died Inoue 1996 53 male lower hepatoid yes yes (LSBE) surgery+ chemotherapy S-1+CDDP 36mo. A��08�"�d��c�z���W0���G�s�� ��qNDŽ�z�d��cSzI��:��!D75��ˈd�ka�xתPO���DOWI�W峟�Y��M���l�څ��f|x��Izw2��i��O�p�]R���I��Ƨp�j������╊N�0�g��Q\���g��2N��Kb���q���ӋEtWE/���pY\'\�}M��E�LO'ciR�V��"Ƭ����K_�eLG�?���S�݁�Q�4Fe��{�5˗��-���ctXF�d�O�1atT��߉X�G����dUf9���IH� L#��?��T��a�=��ҥgx~��2��O8=C/CD��V�F��`�*�X�I�.�D�`:�ʻv�k�z�U��d���3?��U�(;�Mx4�)��&��wG�cjw g.